Product news

GlaxoSmithKline announced the approval of Requip XL(ropinirole extended-release tablets) in the US for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product should be available in pharmacies in mid-July 2008.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.